Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials

被引:4
|
作者
Salazar, Ana S. [1 ]
Rakhmankulova, Malika [1 ]
Simon, Laura E. [2 ]
Toriola, Adetunji T. [1 ]
机构
[1] Washington Univ, Dept Surg, Div Publ Hlth Sci, Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Bernard Becker Med Lib, Sch Med, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
CANCER RISK; YOUNG-WOMEN; ASSOCIATION; MENOPAUSE; TAMOXIFEN; THERAPY; TIME;
D O I
10.1093/jncics/pkaa125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Higher mammographic breast density (MBD) is associated with an increased risk of breast cancer when compared with lower MBD, especially in premenopausal women. However, little is known about the effectiveness of chemoprevention agents in reducing MBD in premenopausal women without a history of breast cancer. Findings from this review should provide insight on how to target MBD in breast cancer prevention in premenopausal women with dense breasts. Methods: We searched 9 electronic databases for clinical trials in English, Spanish, French, or German published until January 2020. Articles evaluating the association of pharmacological agents and MBD were included. Data were extracted on methods, type and dose of intervention, outcomes, side effects, and follow up. Quality of the studies was assessed using the US Preventive Services Task Force criteria. Results: We identified 7 clinical trials evaluating the associations of 6 chemoprevention agents with changes in MBD in premenopausal women without history of breast cancer. The studies evaluated selective estrogen-receptor modulators (n=1); gonadotropin-releasing hormone agonists (n=2); isoflavones (n=1); vitamin D (n=1); and Boswellia, betaine, and mayo-inositol compound (n=1). Hormonal interventions were associated with net reductions in percent density (tamoxifen [13.4%], leuprolide acetate [8.9%], and goserelin [2.7%]), whereas nonhormonal (vitamin D and isoflavone) interventions were not. However, MBD returned to preintervention baseline levels after cessation of gonadotropin-releasing hormone agonists. Conclusions: A limited number of chemoprevention agents have been shown to reduce MBD in premenopausal women. Identification of new and well-tolerated chemoprevention agents targeting MBD and larger studies to confirm agents that have been studied in small trials are urgent priorities for primary breast cancer prevention in premenopausal women with dense breasts.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women
    Kim, Eun Young
    Chang, Yoosoo
    Ahn, Jiin
    Yun, Ji-Sup
    Park, Yong Lai
    Park, Chan Heun
    Shin, Hocheol
    Ryu, Seungho
    CANCER, 2020, 126 (21) : 4687 - 4696
  • [22] Breast Tissue Proteomic Profile of Breast Cancer in Premenopausal Women and Association with Mammographic Breast Density
    Tapiavala, Shaili
    Son, Minsoo
    Colditz, Graham
    Goo, Ah Young
    Toriola, Adetunji
    CANCER RESEARCH, 2024, 84 (09)
  • [23] Milk intake and mammographic density in premenopausal women
    Yunan Han
    Xiaoyu Zong
    Yize Li
    Graham A. Colditz
    Adetunji T. Toriola
    Breast Cancer Research and Treatment, 2019, 174 : 249 - 255
  • [24] Urinary cadmium and mammographic density in premenopausal women
    Adams, Scott V.
    Newcomb, Polly A.
    Shafer, Martin M.
    Atkinson, Charlotte
    Bowles, Erin J. Aiello
    Newton, Katherine M.
    Lampe, Johanna W.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 837 - 844
  • [25] Circulating Hormones and Mammographic Density in Premenopausal Women
    Kimberly A. Bertrand
    A. Heather Eliassen
    Susan E. Hankinson
    Bernard A. Rosner
    Rulla M. Tamimi
    Hormones and Cancer, 2018, 9 : 117 - 127
  • [26] Inclusion of premenopausal women in breast cancer clinical trials
    Corrigan, Kelsey L.
    Kouzy, Ramez
    Jaoude, Joseph Abi
    Patel, Roshal R.
    Layman, Rachel M.
    Giordano, Sharon H.
    Woodward, Wendy A.
    Smith, Benjamin D.
    Shaitelman, Simona F.
    Ludmir, Ethan B.
    BREAST, 2022, 66 : 204 - 207
  • [27] Circulating Hormones and Mammographic Density in Premenopausal Women
    Bertrand, Kimberly A.
    Eliassen, A. Heather
    Hankinson, Susan E.
    Rosner, Bernard A.
    Tamimi, Rulla M.
    HORMONES & CANCER, 2018, 9 (02): : 117 - 127
  • [28] Urinary cadmium and mammographic density in premenopausal women
    Scott V. Adams
    Polly A. Newcomb
    Martin M. Shafer
    Charlotte Atkinson
    Erin J. Aiello Bowles
    Katherine M. Newton
    Johanna W. Lampe
    Breast Cancer Research and Treatment, 2011, 128 : 837 - 844
  • [29] Milk intake and mammographic density in premenopausal women
    Han, Yunan
    Zong, Xiaoyu
    Eapen, Diane Elizabeth
    Li, Yize
    Colditz, Graham A.
    Toriola, Adetunji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Milk intake and mammographic density in premenopausal women
    Han, Yunan
    Zong, Xiaoyu
    Li, Yize
    Colditz, Graham A.
    Toriola, Adetunji T.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (01) : 249 - 255